Related Experiment Video
Updated: May 9, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Interview: an insight into cutting-edge tuberculosis vaccine research. Interview by Katie Lockwood
Abstract:
Else Marie Agger speaks to Katie Lockwood, Assistant Commissioning Editor Else Marie Agger was appointed Director of the Department of Infectious Disease Immunology, Statens Serum Institut in Denmark in 2011. Prior to this, she had been heading two different research groups focusing on tuberculosis (TB) vaccine research and adjuvant development, respectively. She holds a postdoctoral degree within immunology from the University of Copenhagen (Denmark). Agger has extensive experience within adjuvant research, TB vaccine research and preclinical development of vaccines. In addition, she has previously been involved in antigen discovery, primarily with a focus on developing novel diagnostic tests within TB. She has been involved in the coordination of vaccine delivery optimization within the EU-funded TBVAC and NEWTBVAC consortia and also has previous experience as a work-package leader within an EU-funded project, focusing on adjuvantation of influenza vaccines. Agger is the coinventor of several adjuvant patents and has published more than 60 papers within TB, vaccines and adjuvant research.
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Microorganisms in Medicine and Therapeutics
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Vaccinations

